Cargando…

Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes

BACKGROUND: The majority of the U.S. healthcare resources are utilized by a small population characterized as high-risk, high-need persons with complex care needs (e.g., adults with multiple chronic conditions). Substance use disorders (SUDs) and mental health disorders (MHDs) are a driver of poor h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Li-Tzy, Ghitza, Udi E., Zhu, He, Spratt, Susan, Swartz, Marvin, Mannelli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959045/
https://www.ncbi.nlm.nih.gov/pubmed/29554592
http://dx.doi.org/10.1016/j.drugalcdep.2018.01.008
_version_ 1783324322164637696
author Wu, Li-Tzy
Ghitza, Udi E.
Zhu, He
Spratt, Susan
Swartz, Marvin
Mannelli, Paolo
author_facet Wu, Li-Tzy
Ghitza, Udi E.
Zhu, He
Spratt, Susan
Swartz, Marvin
Mannelli, Paolo
author_sort Wu, Li-Tzy
collection PubMed
description BACKGROUND: The majority of the U.S. healthcare resources are utilized by a small population characterized as high-risk, high-need persons with complex care needs (e.g., adults with multiple chronic conditions). Substance use disorders (SUDs) and mental health disorders (MHDs) are a driver of poor health and additional healthcare costs, but they are understudied among high-need patients. OBJECTIVE: We examine the prevalence and correlates of SUDs and MHDs among adults with high-risk diabetes, who are patients at the top 10% risk score for developing poor outcomes (hospital admission or death). METHODS: A risk algorithm developed from Duke University Health System electronic health records (EHRs) data was used to identify patients with high-risk diabetes for targeting home-based primary care. The EHR data of the 263 patients with high-risk diabetes were analyzed to understand patterns of SUDs and MHDs to inform care-coordinating efforts. RESULTS: Both SUDs (any SUD 48.3%, alcohol 12.5%, tobacco 38.8%, drug 23.2%) and MHDs (any MHD 74.9%, mood 53.2%, sleep 37.3%, anxiety 32.7%, schizophrenia/psychotics/delusional 14.8%, dementia/delirium/amnestic/cognitive 14.4%, adjustment 9.1%) were prevalent. Overall, 81.7% of the sample had SUD or MHD. Elevated odds of SUD were noted among men (tobacco, alcohol) and those who were never-married (alcohol, cannabis). African-American race (vs. other race/ethnicity) was associated with lower odds of anxiety disorders. CONCLUSION: While data are limited to one large academic health system, they provide clinical evidence revealing that 82% of patients with high-risk diabetes had SUD and/or MHD recorded in their EHRs, highlighting a need for developing service models to optimize high-risk care.
format Online
Article
Text
id pubmed-5959045
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-59590452018-05-18 Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes Wu, Li-Tzy Ghitza, Udi E. Zhu, He Spratt, Susan Swartz, Marvin Mannelli, Paolo Drug Alcohol Depend Article BACKGROUND: The majority of the U.S. healthcare resources are utilized by a small population characterized as high-risk, high-need persons with complex care needs (e.g., adults with multiple chronic conditions). Substance use disorders (SUDs) and mental health disorders (MHDs) are a driver of poor health and additional healthcare costs, but they are understudied among high-need patients. OBJECTIVE: We examine the prevalence and correlates of SUDs and MHDs among adults with high-risk diabetes, who are patients at the top 10% risk score for developing poor outcomes (hospital admission or death). METHODS: A risk algorithm developed from Duke University Health System electronic health records (EHRs) data was used to identify patients with high-risk diabetes for targeting home-based primary care. The EHR data of the 263 patients with high-risk diabetes were analyzed to understand patterns of SUDs and MHDs to inform care-coordinating efforts. RESULTS: Both SUDs (any SUD 48.3%, alcohol 12.5%, tobacco 38.8%, drug 23.2%) and MHDs (any MHD 74.9%, mood 53.2%, sleep 37.3%, anxiety 32.7%, schizophrenia/psychotics/delusional 14.8%, dementia/delirium/amnestic/cognitive 14.4%, adjustment 9.1%) were prevalent. Overall, 81.7% of the sample had SUD or MHD. Elevated odds of SUD were noted among men (tobacco, alcohol) and those who were never-married (alcohol, cannabis). African-American race (vs. other race/ethnicity) was associated with lower odds of anxiety disorders. CONCLUSION: While data are limited to one large academic health system, they provide clinical evidence revealing that 82% of patients with high-risk diabetes had SUD and/or MHD recorded in their EHRs, highlighting a need for developing service models to optimize high-risk care. 2018-03-03 2018-05-01 /pmc/articles/PMC5959045/ /pubmed/29554592 http://dx.doi.org/10.1016/j.drugalcdep.2018.01.008 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Wu, Li-Tzy
Ghitza, Udi E.
Zhu, He
Spratt, Susan
Swartz, Marvin
Mannelli, Paolo
Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
title Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
title_full Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
title_fullStr Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
title_full_unstemmed Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
title_short Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
title_sort substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959045/
https://www.ncbi.nlm.nih.gov/pubmed/29554592
http://dx.doi.org/10.1016/j.drugalcdep.2018.01.008
work_keys_str_mv AT wulitzy substanceusedisordersandmedicalcomorbiditiesamonghighneedhighriskpatientswithdiabetes
AT ghitzaudie substanceusedisordersandmedicalcomorbiditiesamonghighneedhighriskpatientswithdiabetes
AT zhuhe substanceusedisordersandmedicalcomorbiditiesamonghighneedhighriskpatientswithdiabetes
AT sprattsusan substanceusedisordersandmedicalcomorbiditiesamonghighneedhighriskpatientswithdiabetes
AT swartzmarvin substanceusedisordersandmedicalcomorbiditiesamonghighneedhighriskpatientswithdiabetes
AT mannellipaolo substanceusedisordersandmedicalcomorbiditiesamonghighneedhighriskpatientswithdiabetes